The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
l -Arginine Induces Nitric Oxide–Dependent Vasodilation in Patients With Critical Limb Ischemia: A Randomized, Controlled Study
Abstract
Background l -Arginine is the precursor of endogenous nitric oxide (NO), which is a potent vasodilator acting via the intracellular second-messenger cGMP. In healthy humans, l -arginine induces peripheral vasodilation and inhibits platelet aggregation due to an increased NO production. Prostaglandin E 1 (PGE 1 ) induces peripheral vasodilation via stimulating prostacyclin receptors. Methods and Results We investigated the effects of one intravenous infusion of l -arginine (30 g, 60 minutes) or PGE 1 (40 μg, 60 minutes) versus those of placebo (150 mL 0.9% saline, 60 minutes) on blood pressure, peripheral hemodynamics, and urinary NO 3 − and cGMP excretion rates in patients with critical limb ischemia (peripheral arterial occlusive disease stages Fontaine III or IV). Blood flow in the femoral artery was significantly increased by l -arginine (+42.3±7.9%, P <.05) and by PGE 1 (+31.0±10.2%, P <.05) but not by placebo (+4.3±13.0%, P =NS). Urinary NO 3 − excretion increased by 131.8±39.5% after l -arginine ( P <.05) but only by 32.3±17.2% after PGE 1 ( P =NS). Urinary cGMP excretion increased by 198.7±84.9% after l -arginine ( P <.05) and by 94.2±58.8% after PGE 1 ( P =NS). Both urinary index metabolites were unchanged by placebo. Conclusions We conclude that intravenous l -arginine induces NO-dependent peripheral vasodilation in patients with critical limb ischemia. These effects are paralleled by increased urinary NO 3 − and cGMP excretion, indicating an enhanced systemic NO production. Increased urinary NO 3 − excretion may be a sum effect of NO synthase substrate provision ( l -arginine) and increased shear stress (PGE 1 and l -arginine).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Cyclic guanosine monophosphate as a mediator of vasodilation.
Murad, F. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112536 · Cited by 799
L-Arginine is a precursor for nitrate biosynthesis in humans
Leaf, C. D., Wishnok, J. S., & Tannenbaum, S. R. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92325-5 · Cited by 129
Cited by
Role of nitric oxide in inflammatory diseases
Sharma, J. N., Al-Omran, A., & Parvathy, S. S. (2007) · Inflammopharmacology · doi:10.1007/s10787-007-0013-x · Cited by 1,403
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1560 · Cited by 1,200
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Self-citationEndothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Endothelial dysfunction and vascular disease
Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Feletou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 806
Böger, R. H., Bode-Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490
Self-citationJanaszak-Jasiecka, A., Płoska, A., Wierońska, J. M., Dobrucki, L. W., & Kalinowski, L. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00423-2 · Cited by 358
The l-arginine paradox: Importance of the l-arginine/asymmetrical dimethylarginine ratio
BODEBOGER, S., SCALERA, F., & IGNARRO, L. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.002 · Cited by 347
The Clinical Pharmacology of L-Arginine
Böger, R. H., & Bode-Böger, S. M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.79 · Cited by 331
Böger, R. H., Skamira, C., Bode-Böger, S. M., Brabant, G., von zur Muhlen, A., & Frolich, J. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119095 · Cited by 270
Self-citationBöger, R. H., Bode-Böger, S. M., Thiele, W., Creutzig, A., Alexander, K., & Frölich, J. C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00375-1 · Cited by 264
Self-citationNitrite and Nitrate Analyses: A Clinical Biochemistry Perspective
Ellis, G., Adatia, I., Yazdanpanah, M., & Makela, S. K. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00015-0 · Cited by 264
L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationship
Bode‐Böger, S. M., Böger, R. H., Galland, A., Tsikas, D., & Frölich, J. C. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00803.x · Cited by 259
Self-citationl -Arginine Supplementation in Peripheral Arterial Disease: No Benefit and Possible Harm
Wilson, A. M., Harada, R., Nair, N., Balasubramanian, N., & Cooke, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.683656 · Cited by 241
Endogenous nitric oxide synthase inhibitors are responsible for the L‐arginine paradox
Tsikas, D., Böger, R. H., Sandmann, J., Bode-Böger, S. M., & Frölich, J. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01686-0 · Cited by 237
Self-citationThe Pharmacodynamics of L-Arginine
Böger, R. H. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1650s · Cited by 221
Self-citationHigashi, Y., Sasaki, S., Nakagawa, K., Fukuda, Y., Matsuura, H., Oshima, T., & Chayama, K. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02317-2 · Cited by 173
Mohammadifard, N., Salehi-Abargouei, A., Salas-Salvadó, J., Guasch-Ferré, M., Humphries, K., & Sarrafzadegan, N. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.091595 · Cited by 168
L-Arginine as a Potential Ergogenic Aid in Healthy Subjects
Álvares, T. S., Meirelles, C. M., Bhambhani, Y. N., Paschoalin, V. M. F., & Gomes, P. S. C. (2011) · Sports Medicine · doi:10.2165/11538590-000000000-00000 · Cited by 138
Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Kajiyama, G., & Oshima, T. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01288-1 · Cited by 136
Higashi, Y. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02191-4 · Cited by 125
Nitric Oxide: Implications for Vascular and Endovascular Surgery
Vural, K. M., & Bayazit, M. (2001) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2001.1448 · Cited by 43
Metadata
- Authors
- Bode-Böger, S. M., Böger, R. H., Alfke, H., Heinzel, D., Tsikas, D., Creutzig, A., Alexander, K., & Frölich, J. C.
- Venue
- Circulation
- Published
- 1996-01
- Volume
- 93
- Issue
- 1
- Pages
- 85-90
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1968668382
- Cited by
- 195
- References
- 4
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.